129 related articles for article (PubMed ID: 37904480)
1. Clinical application value of hepatitis B virus basal core promoter 1762/1764 and GGTII and GGT in patients with HBV-DNA-positive primary liver cancer.
Qiu S; Jin L; Yang D; Zhang D
Medicine (Baltimore); 2023 Oct; 102(43):e35699. PubMed ID: 37904480
[TBL] [Abstract][Full Text] [Related]
2. Diagnostic value of gamma-glutamyltransferase/aspartate aminotransferase ratio, protein induced by vitamin K absence or antagonist II, and alpha-fetoprotein in hepatitis B virus-related hepatocellular carcinoma.
Wang Q; Chen Q; Zhang X; Lu XL; Du Q; Zhu T; Zhang GY; Wang DS; Fan QM
World J Gastroenterol; 2019 Sep; 25(36):5515-5529. PubMed ID: 31576097
[TBL] [Abstract][Full Text] [Related]
3. [Clinical course and outcomes of chronic viral hepatitis D in patients from Republic of Tuva as endemic region].
Isaeva OV; Il'chenko LY; Saryglar AA; Karlsen AA; Kyuregyan KK; Mikhailov MI
Vopr Virusol; 2021 Mar; 66(1):74-83. PubMed ID: 33683068
[TBL] [Abstract][Full Text] [Related]
4. Mutations in pre-core and basic core promoter regions of hepatitis B virus in chronic hepatitis B patients.
Wang XL; Ren JP; Wang XQ; Wang XH; Yang SF; Xiong Y
World J Gastroenterol; 2016 Mar; 22(11):3268-74. PubMed ID: 27004005
[TBL] [Abstract][Full Text] [Related]
5. The gamma-glutamyl transpeptidase to platelet ratio predicts liver inflammation in chronic hepatitis B with normal or mildly elevated alanine transaminase.
Wang J; Xia J; Yan X; Yang Y; Wei J; Xiong Y; Wu W; Liu Y; Chen Y; Jia B; Chen Z; Zhang Z; Ding W; Huang R; Wu C
Clin Res Hepatol Gastroenterol; 2020 Nov; 44(6):913-922. PubMed ID: 32147439
[TBL] [Abstract][Full Text] [Related]
6. Noninvasive diagnosis of significant liver inflammation in patients with chronic hepatitis B in the indeterminate phase.
Zhan J; Wang J; Zhang Z; Xue R; Jiang S; Liu J; Liu Y; Zhu L; Xia J; Yan X; Ding W; Zhu C; Qiu Y; Li J; Huang R; Wu C
Virulence; 2023 Dec; 14(1):2268497. PubMed ID: 37938933
[TBL] [Abstract][Full Text] [Related]
7. [Analysis of the relationship between hepatitis B virus precore and basal core promoter mutations and acute-on-chronic liver failure].
Ma XY; Han T; Pei YZ; Zhao ZG; Gao YT; Li Y; Jing L
Zhonghua Gan Zang Bing Za Zhi; 2012 Sep; 20(9):644-8. PubMed ID: 23207226
[TBL] [Abstract][Full Text] [Related]
8. Hepatitis B virus basal core promoter/precore mutants and association with liver cirrhosis in children with chronic hepatitis B virus infection.
Zhong YW; Di FL; Liu C; Zhang XC; Bi JF; Li YL; Wu SQ; Dong H; Liu LM; He J; Shi YM; Zhang HF; Zhang M
Clin Microbiol Infect; 2016 Apr; 22(4):379.e1-379.e8. PubMed ID: 26577140
[TBL] [Abstract][Full Text] [Related]
9. Relationship between hepatitis B virus DNA levels and liver histology in patients with chronic hepatitis B.
Shao J; Wei L; Wang H; Sun Y; Zhang LF; Li J; Dong JQ
World J Gastroenterol; 2007 Apr; 13(14):2104-7. PubMed ID: 17465456
[TBL] [Abstract][Full Text] [Related]
10. Alanine aminotransferase is more sensitive to the decrease in hepatitis B virus-DNA load than other liver markers in chronic hepatitis B patients.
Wang HB; Wang QY; Yuan Q; Shan XY; Fu GH
J Clin Lab Anal; 2017 Nov; 31(6):. PubMed ID: 28116822
[TBL] [Abstract][Full Text] [Related]
11. Mutations in basal core promoter is associated with significant fibrosis in both HBeAg positive and negative treatment-naïve chronic hepatitis B.
Yan LB; Zhu X; Bai L; Tang XQ; Du LY; Chen EQ; Liang LB; Tang H
Clin Res Hepatol Gastroenterol; 2017 Jun; 41(3):296-302. PubMed ID: 27988305
[TBL] [Abstract][Full Text] [Related]
12. [Clinical significance of serum glutamyl transpeptidase in chronic hepatitis B].
Xian YC; Yang JY; Xu R; Huang CJ; Wu LL
Zhonghua Shi Yan He Lin Chuang Bing Du Xue Za Zhi; 2007 Dec; 21(4):383-5. PubMed ID: 18322611
[TBL] [Abstract][Full Text] [Related]
13. [Clinical value of plasma scaffold protein SEC16A in evaluating hepatitis B-related liver cirrhosis and hepatocellular carcinoma].
Dong C; Chang CD; Zhao DD; Zhang XX; Guo PL; Dou Y; Zhao SX; Nan YM
Zhonghua Gan Zang Bing Za Zhi; 2023 Jun; 31(6):621-626. PubMed ID: 37400387
[No Abstract] [Full Text] [Related]
14. Pre-core/basal-core promoter and reverse transcriptase mutations in chronic HBV infected-patients.
Xu L; Chen EQ; Lei J; Liu L; Zhou TY; Gao Z; Tang H
Hepatogastroenterology; 2012; 59(113):212-5. PubMed ID: 22251541
[TBL] [Abstract][Full Text] [Related]
15. Presence of Precore (C)/C Promoter Mutants in Peripheral Blood Mononuclear Cells of Chronic Hepatitis B (CHB) Carriers During Pregnancy Does Not Correlate with Increased Risk of Liver Disease in 4 Years of Follow-Up.
Joshi SS; Gao S; Castillo E; Coffin CS
Dig Dis Sci; 2020 Jan; 65(1):204-214. PubMed ID: 31376084
[TBL] [Abstract][Full Text] [Related]
16. Combination of quantitative hepatitis B core antibody (qHBcAb) and aspartate aminotransferase (AST) can accurately diagnose immune tolerance of chronic hepatitis B virus infection based on liver biopsy.
Chi Z; Zhao W; Li JW; Liu H; Shao C; Zhao H; Gui-Qiang W
Clin Res Hepatol Gastroenterol; 2021 Nov; 45(6):101563. PubMed ID: 33272888
[TBL] [Abstract][Full Text] [Related]
17. [Clinical significance of serum HBsAg levels, HBsAg/HBV DNA ratio, and association with liver inflammation activity in HBeAg-positive chronic hepatitis B].
Li G; Wang J; Bao Y; Zheng L; Ge K; Zhou X; Chen G
Zhonghua Gan Zang Bing Za Zhi; 2015 Jan; 23(1):40-5. PubMed ID: 25751385
[TBL] [Abstract][Full Text] [Related]
18. Clinical and virological characteristics of chronic hepatitis B patients with hepatic steatosis.
Zheng RD; Chen JN; Zhuang QY; Lu YH; Chen J; Chen BF
Int J Med Sci; 2013; 10(5):641-6. PubMed ID: 23569427
[TBL] [Abstract][Full Text] [Related]
19. The gamma-glutamyl transpeptidase-to-platelet ratio predicts liver fibrosis and cirrhosis in HBeAg-positive chronic HBV infection patients with high HBV DNA and normal or mildly elevated alanine transaminase levels in China.
Li Q; Li W; Huang Y; Chen L
J Viral Hepat; 2016 Nov; 23(11):912-919. PubMed ID: 27375134
[TBL] [Abstract][Full Text] [Related]
20. Hepatitis B virus genotypes, precore mutations, and basal core promoter mutations in HBV-infected Chinese patients with persistently normal alanine aminotransferase and low serum HBV-DNA levels.
Shi M; Zhang Y; Zhang J; Liu W; Xing L
Braz J Infect Dis; 2012; 16(1):52-6. PubMed ID: 22358356
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
